| CLI / Lung |
Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia |
| CLI / Lung |
Treatment of peripheral arterial disease using stem and progenitor cell therapy |
| CLI / Lung |
Intraoperative adjunctive stem cell treatment in patients with critical limb ischemia using a novel point-of-care device |
| CLI / Lung |
No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia |
| CLI / Lung |
Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia |
| CLI / Lung |
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design |
| CLI / Lung |
Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review |
| CLI / Lung |
Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells |
| Heart |
Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction |
| Heart |
Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease |
